Analgesics - Central & Western Europe

  • Central & Western Europe
  • In Central & Western Europe, the revenue generated in the Analgesics market in 2024 amounts to US$4.49bn.
  • It is projected that the market will experience an annual growth rate of 5.61% from 2024 to 2029 (CAGR 2024-2029).
  • When compared globally, the in the United States leads in revenue generation, with a total of US$7,243.00m in 2024.
  • In terms of per capita figures, each individual in Central & Western Europe contributes US$13.39 to the revenue in 2024.
  • In Central & Western Europe, Germany has seen a rise in the popularity of natural and herbal analgesics in the OTC Pharmaceuticals market.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Central & Western Europe is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Analgesics market in Central & Western Europe are driving the growth of the industry. Consumers in this region are increasingly seeking pain relief solutions that are effective, affordable, and convenient. They are looking for analgesic products that provide quick and long-lasting relief from pain, without causing any side effects. Additionally, there is a growing demand for natural and herbal remedies in the market, as consumers are becoming more conscious about the ingredients used in the products they consume. Trends in the market are also contributing to the growth of the Analgesics industry in Central & Western Europe. One major trend is the increasing adoption of e-commerce platforms for purchasing analgesic products. Online shopping offers convenience, a wide range of options, and competitive pricing, which is appealing to consumers. The rise of e-commerce has also led to the emergence of direct-to-consumer brands that offer personalized and niche analgesic products. Another trend is the growing popularity of combination analgesics, which offer a combination of different active ingredients to target multiple types of pain. Combination analgesics are preferred by consumers as they provide a more comprehensive pain relief solution.Local special circumstances in Central & Western Europe are also influencing the development of the Analgesics market. The aging population in this region is a significant factor driving the demand for analgesic products. As people age, they are more likely to experience chronic pain conditions, such as arthritis, which require long-term pain management solutions. Additionally, the high prevalence of musculoskeletal disorders in the region is contributing to the demand for analgesics. The sedentary lifestyle and desk-bound work culture in many countries in Central & Western Europe are leading to an increase in musculoskeletal disorders, resulting in a higher demand for pain relief solutions.Underlying macroeconomic factors are also playing a role in the growth of the Analgesics market in Central & Western Europe. The region has a stable and growing economy, which has led to an increase in disposable income among consumers. This has allowed them to spend more on healthcare and wellness products, including analgesics. Additionally, the healthcare infrastructure in Central & Western Europe is well-developed, with easy access to healthcare facilities and services. This facilitates the availability and distribution of analgesic products, further driving the market growth.Overall, the Analgesics market in Central & Western Europe is developing due to customer preferences for effective and affordable pain relief solutions, trends in the market such as the rise of e-commerce and the popularity of combination analgesics, local special circumstances like the aging population and high prevalence of musculoskeletal disorders, and underlying macroeconomic factors such as a stable economy and well-developed healthcare infrastructure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)